Since the outbreak of COVID-19,with the emergence of a series of novel coronavirus variants of different types,COVID-19 has continued to spread across the globe,posing a huge threat to the lives and health of people a...Since the outbreak of COVID-19,with the emergence of a series of novel coronavirus variants of different types,COVID-19 has continued to spread across the globe,posing a huge threat to the lives and health of people around the world and posing a severe challenge to global public health security.Recently,the World Health Organization(WHO)announced that novel coronavirus variant strain"Omicron"subtype variant strain BA.2 has been found in 57 countries and regions.It has higher vaccine and antibody tolerance and is more infectious than omicron(B.1.1.529).In this paper,we briefly review the recent studies on the omicron subtype variant strain BA.2.展开更多
The corona virus disease 2019(COVID-19)is an acute respiratory infection caused by the binding of SEVERE acute respiratory syndrome coronavirus 2(SARS-COV-2)and the angiotensin-converting enzyme 2(ACE2)receptor to the...The corona virus disease 2019(COVID-19)is an acute respiratory infection caused by the binding of SEVERE acute respiratory syndrome coronavirus 2(SARS-COV-2)and the angiotensin-converting enzyme 2(ACE2)receptor to the host target organ.New research suggests that COVID-19 may be a systemic infectious disease and a systemic inflammatory disease.Symptoms and signs of the digestive system are often found in patients with coVID-19 following acute infection.At present,despite the existence of some coronavirus-related digestive diseases(such as gastrointestinal diseases,liver injury,pancreatic injury,etc.),the pathogenesis of COVID-19 with digestive symptoms in existing studies is still unclear,and relevant guidelines and expert consensus are not enough for clinical diagnosis and treatment.Therefore,it is extremely important to understand the clinical manifestations,pathogenesis and prognosis of coVID-19 patients with digestive system.展开更多
基金The 940th Hospital Intra-Hospital Fund Project(No.20yjky020)the Huoshenshan Hospital Research Fund General Project(No.HSS-217)。
文摘Since the outbreak of COVID-19,with the emergence of a series of novel coronavirus variants of different types,COVID-19 has continued to spread across the globe,posing a huge threat to the lives and health of people around the world and posing a severe challenge to global public health security.Recently,the World Health Organization(WHO)announced that novel coronavirus variant strain"Omicron"subtype variant strain BA.2 has been found in 57 countries and regions.It has higher vaccine and antibody tolerance and is more infectious than omicron(B.1.1.529).In this paper,we briefly review the recent studies on the omicron subtype variant strain BA.2.
基金The 940th Hospital Intra-Hospital Fund Project(No.20yjky020)the General Project of Huoshenshan Hospital Scientific Research Fund(No.HSS-217)the Gansu Provincial Department of Science and Technology Social Development Department Clinical Medical Research Center Project(No.21JR7RA017)。
文摘The corona virus disease 2019(COVID-19)is an acute respiratory infection caused by the binding of SEVERE acute respiratory syndrome coronavirus 2(SARS-COV-2)and the angiotensin-converting enzyme 2(ACE2)receptor to the host target organ.New research suggests that COVID-19 may be a systemic infectious disease and a systemic inflammatory disease.Symptoms and signs of the digestive system are often found in patients with coVID-19 following acute infection.At present,despite the existence of some coronavirus-related digestive diseases(such as gastrointestinal diseases,liver injury,pancreatic injury,etc.),the pathogenesis of COVID-19 with digestive symptoms in existing studies is still unclear,and relevant guidelines and expert consensus are not enough for clinical diagnosis and treatment.Therefore,it is extremely important to understand the clinical manifestations,pathogenesis and prognosis of coVID-19 patients with digestive system.
